MICHELLE VAZQUEZ: Open Payments
NPI 1518502897 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 33 payments from 12 companies in 2025. Trend: 2023 $334 · 2024 $301 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $149 |
| ABBVIE INC. | 4 | $83 |
| Ardelyx, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| GENZYME CORPORATION | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Braintree Laboratories, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, RINVOQ, IBSRELA, VOQUEZNA, ENTYVIO, OMVOH, SUFLAVE.
Industry payments across IN — which companies pay providers there.
